Our results, demonstrating that CXCL1 serum levels were significantly reduced in B16/PTGS2Δ melanoma bearing mice, are completely in line with these findings and further support the ability of PTGS2 to regulate CXCL1 secretion in melanoma. This evidence concerns the gene PTGS2 and melanoma.